Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Financial Results

Set Alert for Financial Results

Latest From Financial Results

Aratana Q4 sees dip, as full year provides stronger growth platform

Aratana Therapeutics reported a 53% drop in sales to $4.9 million during the fourth quarter of 2018, due to a large one-off payment made last year.

Aratana Therapeutics Financial Results

Avivagen sustains high growth in Q1, net loss improves

Early-stage Canadian firm Avivagen has posted a sturdy growth in sales in the first quarter of 2019.

Financial Results

KindredBio loss widens in early commercial stages, firm shows positive initial growth

Kindred BioSciences has reported sales of $1.3 million in the fourth quarter of 2018, around five months after commercializing its lead product.

Kindred Biosciences Financial Results

Competition drags down Perrigo annual sales by 33%

Perrigo's animal health business has reported an annual sales decline for the fourth year in a row.

Perrigo Financial Results

Revitalized Ouro Fino continues strong growth into Q4

Brazil's Ouro Fino Saúde Animal has maintained its comeback with 8% sales growth in the fourth quarter of 2018.

Ouro Fino Saude Animale Financial Results

Zomedica loss doubles in 2018 following year focused on R&D

Zomedica Pharmaceuticals' net loss doubled in 2018 on the back of a heavy R&D focus throughout the year.

Financial Results R&D
See All